Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 23:12:85-96.
doi: 10.1016/j.bioactmat.2021.10.026. eCollection 2022 Jun.

In vivo performance of a rare earth free Mg-Zn-Ca alloy manufactured using twin roll casting for potential applications in the cranial and maxillofacial fixation devices

Affiliations

In vivo performance of a rare earth free Mg-Zn-Ca alloy manufactured using twin roll casting for potential applications in the cranial and maxillofacial fixation devices

Matthew S Dargusch et al. Bioact Mater. .

Abstract

A magnesium alloy containing essential, non-toxic, biodegradable elements such as Ca and Zn has been fabricated using a novel twin-roll casting process (TRC). Microstructure, mechanical properties, in vivo corrosion and biocompatibility have been assessed and compared to the properties of the rare earth (RE) element containing WE43 alloy. TRC Mg-0.5 wt% Zn- 0.5 wt% Ca exhibited fine grains with an average grain size ranging from 70 to 150 μm. Mechanical properties of a TRC Mg-0.5Zn-0.5Ca alloy showed an ultimate tensile strength of 220 MPa and ductility of 9.3%. The TRC Mg-0.5Zn-0.5Ca alloy showed a degradation rate of 0.51 ± 0.07 mm/y similar to that of the WE43 alloy (0.47 ± 0.09 mm/y) in the rat model after 1 week of implantation. By week 4 the biodegradation rates of both alloys studied were lowered and stabilized with fewer gas pockets around the implant. The histological analysis shows that both WE43 and TRC Mg-0.5Zn-0.5Ca alloy triggered comparable tissue healing responses at respective times of implantation. The presence of more organized scarring tissue around the TRC Mg-0.5Zn-0.5Ca alloys suggests that the biodegradation of the RE-free alloy may be more conducive to the tissue proliferation and remodelling process.

Keywords: Biocompatibility; Biodegradable implants; In vivo degradation; Mg–Zn–Ca alloy; Twin-roll strip casting.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Polarised light microscopic images of (a–c) TRC Mg–Zn–Ca alloy and (d) WE43 alloy [56].
Fig. 2
Fig. 2
Backscattered electron (BSE) images of (a, b) TRC Mg–Zn–Ca alloy and (c, d) WE43 alloy at (a, c) low and (b, d) high magnifications respectively.
Fig. 3
Fig. 3
(a) Bright-field optical image of the deformed region with recrystallized grains along the parallel direction. (b, c) Inverse pole figures at two random locations where (b1, c1) are the ODFs and (b2, c2) are the distribution of misorientation angles.
Fig. 4
Fig. 4
(a) Tensile load curves and (b) summary of the mechanical properties of TRC Mg–Zn–Ca alloy and WE43 alloy.
Fig. 5
Fig. 5
In vivo corrosion rate of TRC Mg–Zn–Ca and WE43 alloys after 1 week and 4 weeks of implantation (asterisk represent statistical significance: *p < 0.05 and NS represent no significance).
Fig. 6
Fig. 6
Representative 3D reconstructed μ-CT images showing the presence of gas around (a, b) TRC Mg–Zn–Ca and (c, d) WE43 implant within rat model after 1 week and 4 weeks. (e, h) Histograms of the gas pocket size in (e, f) TRC Mg–Zn–Ca alloy and (g, h) WE43 alloy implant group after 1 week and 4 weeks of implantation.
Fig. 7
Fig. 7
Histological appearance of the H&E stained tissue after (a, b) 1 week and (c, d) 4 weeks of in vivo testing. The inserted images in (a) and (b) show macrophages lining the pocket wall for TRC Mg-0.5Zn-0.5Ca alloy and multinucleate giant cells and macrophages for WE43 alloy respectively (indicated by *). Dashed lines indicate the tissue in direct contact with the implant.

References

    1. Klammert U., Gbureck U., Vorndran E., Rödiger J., Meyer-Marcotty P., Kübler A.C. 3D powder printed calcium phosphate implants for reconstruction of cranial and maxillofacial defects. J. Cranio-Maxillo-Fac. Surg. 2010;38:565–570. doi: 10.1016/j.jcms.2010.01.009. - DOI - PubMed
    1. Yu Y., Liu W., Chen J., Quan L., Zheng X., Liu L. No need to routinely remove titanium implants for maxillofacial fractures. J. Oral Maxillofac. Surg. 2019;77:783–788. doi: 10.1016/j.joms.2018.10.022. - DOI - PubMed
    1. Ogunbowale A., Costello L., McCormack D., Ekanayake K., Kearns G.J. Maxillofacial fractures in females: a 5-year retrospective review. Ir. J. Med. Sci. 2021 doi: 10.1007/s11845-021-02534-1. - DOI - PubMed
    1. Jaber M.A., AlQahtani F., Bishawi K., Kuriadom S.T. Patterns of maxillofacial injuries in the Middle East and North Africa: a systematic review. Int. Dent. J. 2021 doi: 10.1111/idj.12587. - DOI - PMC - PubMed
    1. Patowary M.H.S.S., Rahman S. Ab, Wan Ahmed M., Liszen T., Shaari R. Correlation among the fractured facial bones in a teaching hospital in Malaysia: a retrospective study of recent 5-years. J. Oral Maxillofac. Surg. Med. Pathol. 2020;32:14–18. doi: 10.1016/j.ajoms.2019.10.014. - DOI

LinkOut - more resources